Temas
Mostrando ítems 1-1 de 1
-
State of the art in anti-cancer mAbs
(2017-02-20)Following Milstein’s discovery, the monoclonal antibodies (mAbs) became a basic tool for biomedical science. In cancer field, since the first mAb was approved by the FDA a great improvement took place making of them a ...